IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 124, 102725
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pathogenesis of Antineutrophil Cytoplasmic Autoantibody–Associated Small-Vessel VasculitisAnnual Review of Pathology: Mechanisms of Disease, 2013
- Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunityBlood, 2012
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- IgG anti-pentraxin 3 antibodies in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2010
- ANCA DiseaseJournal of the American Society of Nephrology, 2010
- Pentraxins, humoral innate immunity and tissue injuryCurrent Opinion in Immunology, 2008
- The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular trapsJournal of Experimental Medicine, 2007
- Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studiesAnnals of the Rheumatic Diseases, 2007
- Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small‐vessel vasculitisArthritis & Rheumatism, 2006
- The American College of Rheumatology 1990 criteria for the classification of vasculitis: SummaryArthritis & Rheumatism, 1990